Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 up 0.1%, FTSE 250 adds 0.1%
Dec 30 (Reuters) - London's FTSE 100 inched higher on
Wednesday after Britain approved a coronavirus vaccine developed
by AstraZeneca and Oxford University, although surging COVID-19
cases in the country kept investors cautious.
The blue-chip FTSE 100 .FTSE rose 0.1% by 0803 GMT,
struggling to break past a fresh 10-month high hit in the
previous session.
Drugmaker AstraZeneca AZN.L rose 1.6%, giving the biggest
boost to the index, after the company said it is working with
the government to begin vaccinations early next year.
The regulatory approval is a welcome boost for AstraZeneca
and the Oxford team, which has been accused of lack of clarity
about the results from late-stage trials. The mid-cap FTSE 250 index .FTMC , considered a barometer
of Brexit sentiment, rose 0.1%. British lawmakers will vote on
the UK-EU trade deal in parliament later in the day.